RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

iGenomics (analysis of DNA)

Product
Developers: Cold Spring Harbor Laboratory (CSHL)
Date of the premiere of the system: November, 2020
Branches: Pharmaceutics, medicine, health care

2020: The announcement of iGenomics - the DNA mobile analyzer

At the beginning of December, 2020 scientists of Cold Spring Harbor Laboratory (CSHL) developed the first-ever mobile analyzer of the sequence of a genome. The new application for iPhone received the name iGenomics and can be used in field conditions by the specialists dealing with issues of a pandemic and ecology.

The application was developed in addition to the tiny devices for DNA sequencing made by Oxford Nanopore. As the developer of the project Aspyn Palatnick, nowadays the software engineer in Facebook acted. He came to CSHL laboratory the 14-year-old trainee from high school and quickly captured a key part of the problem:

File:Aquote1.png
Though sequenators became less and less, the available technologies allowing to study DNA on the mobile device still were not. The most part of studying of a genome was executed on big server clusters or high-class notebooks.
File:Aquote2.png

Aspen Palatnik, developer of the iGenomics project

The associate professor of CSHL Michael Schatz recognized that scientists should carry with themselves a set of the equipment everywhere that complicates a research. Under the leadership of Schatz Palatnik began to write the code for iGenomics - applications which will be able to make genome researches more portable and available. Work lasted eight years, but now users will be able to carry out the analysis of DNA in the most remote places - even to where there is no Internet access.

DNA analyzer

Palatnik and Schatz explained that the algorithm iGenomics can quickly display the sequences of DNA of virus pathogens, such as virus of flu or Zika virus and to define the mutations important for diagnostics and treatment. They also provide the online guide to the analysis of other virus genomes, for example, of the patient's samples with SARS-CoV-2.

File:Aquote1.png
Today all of us carry professional cameras in pockets, and it is easy to provide that in the next few years all will have DNA own sequenators on smartphones, - Schatz considers.[1][2]
File:Aquote2.png

Notes